We're Here for You!
The IMF is dedicated to improving the quality of life of myeloma patients while working toward prevention and a cure.
Ready to nurture your resilience? Follow the IMF's Myeloma Action Month (MAM) March calendar that features "31 Days of Resilience.” The focus is on small actions you can do each day of the week. Some examples include taking a walk, catching up with a family member, or watching the sunrise. And, if you are not up for the daily action, perhaps you will choose to share a fact about myeloma on your social media channels. The ways to get involved this March are easy and varied, so take a look at the MAM website to get your creative juices flowing!
Watch the replay of the Living Well with Myeloma webinar. Featured speakers are IMF Chairman of the Board Dr. Brian G.M. Durie and Dr. Susan Dunnett, a Senior Lecturer at the University of Edinburgh in Scotland. This uplifting sixty-minute webinar will include a segment for questions and answers from participants.
New research shows masks significantly decrease COVID-19 spread. IMF Chairman Dr. Brian G.M. Durie says double mask even as vaccinations roll out.
On February 26, 2021, Oncopeptides "announced that the U.S. Food and Drug Administration, FDA, has approved PEPAXTO® (melphalan flufenamide, also known as melflufen), in combination with dexamethasone, for the treatment of adult patients with relapsed or refractory multiple myeloma, who have received at least four prior lines of therapy and whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one CD38-directed monoclonal antibody."
Myeloma Action Month takes place every March to encourage individuals and groups to take actions that positively impact the myeloma community. This year the IMF invites you to join the myeloma community and nurture your own resilience. Read the full press release to learn more, and then follow along at mam.myeloma.org to start your 31 days of resilience.
Need to stay informed about the news that impacts myeloma patients, but don’t have time to read everything out there? Then be sure to follow Dr. Brian Durie’s Week in Review blog. The leading myeloma expert and IMF Chairman of the Board drills down on a wide range of topics – from the latest myeloma research results to the environmental issues that offer insight into prevention. He sifts through the data to deliver the bottom line.
Last year marks the International Myeloma Foundation's (IMF) 30th anniversary, celebrating 30 years of scientific achievement with myeloma patient care at the heart of it all. What started in a garage with a borrowed typewriter is now the largest organization focused specifically on multiple myeloma. The IMF continues to push the needle forward toward a cure for myeloma with cure-focused trials and over 40 active research projects around the world. As IMF President and Founder Susie Durie says, "We are this close to the cure. I can see it on the horizon."
The IMF stands together with the Black community in calling for justice and racial equality. We believe unconditionally, that Black lives matter.
The support of loved ones allows us to continue to fund efforts to search for a cure. Check out how Fundraisers are helping in the fight against myeloma.
